Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $10.92 $17.05 Thursday, 9th May 2024 SAGE stock ended at $12.34. This is 0.404% less than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 2.87% from a day low at $12.20 to a day high of $12.55.
90 days $10.92 $27.39
52 weeks $10.92 $59.98

Historical Sage Therapeutics prices

Date Open High Low Close Volume
Aug 29, 2023 $19.95 $20.25 $19.70 $19.86 637 179
Aug 28, 2023 $19.76 $20.23 $19.65 $19.94 610 117
Aug 25, 2023 $19.65 $20.20 $19.48 $19.93 627 134
Aug 24, 2023 $19.68 $19.82 $19.43 $19.77 635 385
Aug 23, 2023 $19.84 $20.38 $19.74 $19.75 671 315
Aug 22, 2023 $19.56 $19.90 $19.41 $19.75 1 009 622
Aug 21, 2023 $19.80 $20.02 $19.56 $19.63 994 194
Aug 18, 2023 $19.82 $20.33 $19.64 $19.87 1 414 226
Aug 17, 2023 $20.31 $20.48 $19.75 $20.01 1 443 260
Aug 16, 2023 $21.04 $21.26 $20.34 $20.37 2 088 772
Aug 15, 2023 $21.60 $21.65 $20.60 $21.25 1 515 782
Aug 14, 2023 $21.55 $21.84 $20.84 $21.63 1 819 356
Aug 11, 2023 $19.47 $21.81 $19.44 $21.77 3 104 388
Aug 10, 2023 $18.88 $19.71 $18.55 $19.36 2 207 855
Aug 09, 2023 $18.97 $19.50 $18.60 $18.99 2 806 360
Aug 08, 2023 $16.70 $19.08 $16.60 $18.93 7 413 825
Aug 07, 2023 $18.80 $19.53 $16.52 $16.75 19 328 313
Aug 04, 2023 $36.00 $36.63 $35.63 $36.10 1 644 561
Aug 03, 2023 $36.74 $37.17 $35.97 $36.01 1 267 512
Aug 02, 2023 $35.39 $36.93 $35.38 $36.74 1 280 809
Aug 01, 2023 $34.51 $36.30 $33.55 $36.00 1 823 875
Jul 31, 2023 $35.11 $35.64 $33.52 $34.68 1 754 117
Jul 28, 2023 $35.95 $36.08 $34.18 $34.96 1 921 462
Jul 27, 2023 $36.88 $36.99 $35.79 $35.80 1 499 490
Jul 26, 2023 $41.36 $41.67 $35.66 $36.21 3 772 197
Click to get the best stock tips daily for free!

About Sage Therapeutics

Sage Therapeutics Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive steroid, which is in Phase III clinical trials for treating PPD, major depressive disorders, treatment... SAGE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT